Vimarsana
Biggest News Aggregation in the World

John Glod News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Glod. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Glod Today - Breaking & Trending Today

Drug Approved to Help Young Patients Battle a Rare Cancer - Vimarsana News

Drug Approved to Help Young Patients Battle a Rare Cancer

MONDAY, Jan. 2, 2023 (HealthDay News) -- Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big

Source: vtcng.com
New compound could be effective treatment option for deadly childhood cancer - Vimarsana News

New compound could be effective treatment option for deadly childhood cancer

New research from VCU Massey Cancer Center published last month in Cell Reports demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.

Novel targeted therapy could be effective treatment option for deadly childhood cancer - Vimarsana News

Novel targeted therapy could be effective treatment option for deadly childhood cancer

RICHMOND, Va. — New research from VCU Massey Cancer Center — published this week in Cell Reports — demonstrated that a novel targeted therapy could be an effective treatment option

Novel targeted therapy may be an effective treatment option for neuroblastoma - Vimarsana News

Novel targeted therapy may be an effective treatment option for neuroblastoma

New research from VCU Massey Cancer Center -; published Thursday in Cell Reports -; demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.

Abundance of iron drives cell death and could inform novel treatments for neuroblastoma - Vimarsana News

Abundance of iron drives cell death and could inform novel treatments for neuroblastoma

 E-Mail IMAGE: This image shows expression of a specific ferroptosis marker called TfR1 in MYCN-amplified neuroblastoma tissues before and after treatment with auranofin, an FDA-approved drug for rheumatoid arthritis. view more  Credit: VCU Massey Cancer Center Neuroblastoma is a cancer that develops in nerve tissue, most commonly in the glands around the kidneys. The gene MYCN is overexpressed in 20-25% of neuroblastoma, and MYCN-amplified neuroblastoma contributes to a considerable percentage of pediatric cancer-related deaths. Anthony Faber, Ph.D., and a team of researchers at VC...